Go Deep
Royalty Pharma plc
Royalty Pharma plc Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,027 | 30.3 | 4.81 | 0.92 | 5,505.91 |
| Oct 2026 | 17,924 | 30.7 | 4.89 | 0.92 | 5,531.89 |
| Oct 2026 | 18,528 | 30.1 | 4.78 | 0.92 | 5,387.37 |
| Oct 2026 | 18,237 | 31.4 | 4.99 | 0.92 | 5,600.95 |
| Oct 2026 | 18,162 | 30.4 | 5.04 | 0.92 | 5,661.58 |
| Oct 2026 | 17,999 | 32.4 | 5.16 | 0.92 | 5,773.82 |
| Oct 2026 | 18,082 | 32.1 | 5.10 | 0.92 | 5,714.58 |
| Oct 2026 | 17,844 | 33.1 | 5.26 | 0.92 | 5,902.32 |
| Oct 2026 | 17,856 | 33.1 | 5.26 | 0.92 | 5,878.28 |
| Oct 2026 | 17,663 | 33.9 | 5.39 | 0.92 | 6,017.41 |
| Oct 2026 | 17,650 | 34.0 | 5.40 | 0.92 | 6,052.79 |
Royalty Pharma plc Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 674,141,000.0 | 630,576,000.0 | 621,990,000.0 | 609,291,000.0 |
| Net Profit | 17,883,000.0 | 294,690,000.0 | 214,205,000.0 | 288,217,000.0 |
| EPS | 0.0 | 0.7 | 0.5 | 0.7 |
Royalty Pharma plc Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 2,378,193,000.0 | 2,263,576,000.0 | 2,354,554,000.0 | 2,237,215,000.0 | — |
| Net Profit | 770,947,000.0 | 858,983,000.0 | 1,134,834,000.0 | 42,832,000.0 | — |
| EPS | 1.8 | 1.9 | 2.5 | 0.1 | — |
Royalty Pharma plc Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 19,620,780,000.0 | 18,222,715,000.0 | 16,381,851,000.0 | 16,813,466,000.0 | — |
| Total Liabilities | 9,905,841,000.0 | 7,880,349,000.0 | 6,297,562,000.0 | 7,288,093,000.0 | — |
| Total Equity | 6,476,900,000.0 | 6,946,581,000.0 | 6,526,497,000.0 | 5,628,150,000.0 | — |
Owes vs Owns
Royalty Pharma plc owed $0.51 for every $1 it owned in Jun 2026, up from $0.43 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.51× | 0.50× | 0.43× | 0.38× | 0.43× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Royalty Pharma plc Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 7.6%Intangible assets 4.7%Long-term investments 87.1%
How it's funded — Dec 2025
Short-term debt 1.9%Long-term debt 43.7%Other liabilities 4.8%Shareholders' equity 49.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,491.9 | 1,771.0 | 1,233.7 | 2,427.8 |
| Receivables | 29.3 | 27.0 | 22.4 | 36.6 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 924.6 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 17,088.8 | 16,387.0 | 15,101.1 | 14,228.9 |
| Other assets | 86.2 | 37.7 | 24.6 | 120.1 |
| Liabilities & equity | ||||
| Short-term debt | 380.0 | 997.8 | 0.0 | 997.5 |
| Long-term debt | 8,570.9 | 6,614.7 | 6,135.3 | 6,118.8 |
| Payables | 19.4 | 13.4 | 15.2 | 7.9 |
| Other liabilities | 935.5 | 254.6 | 147.1 | 163.9 |
| Shareholders' equity | 9,714.9 | 10,342.4 | 10,084.3 | 9,525.4 |
| Net tangible assets | 5,552.3 | 6,946.6 | 6,526.5 | 5,628.1 |
Royalty Pharma plc Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 2,489,823,000.0 | 2,768,986,000.0 | 2,987,802,000.0 | 2,143,980,000.0 | — |
| Investing Activities | -1,614,180,000.0 | -2,678,115,000.0 | -2,072,789,000.0 | -1,029,421,000.0 | — |
| Financing Activities | -1,185,973,000.0 | 361,145,000.0 | -2,148,754,000.0 | -944,856,000.0 | — |